Zanganeh Mahkam - Insider Non-Derivative Transactions at Summit Therapeutics Inc. (SMMT) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 11, 2024, Zanganeh Mahkam's relationship to Summit Therapeutics Inc. (SMMT) is Director,Officer (Co-Chief Executive Officer), and currently has 24,967,852 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SMMT insiders.

Data Source: SEC.
Zanganeh Mahkam - Insider Non-Derivative Transactions of SMMT Common Stock
Zanganeh Mahkam - Insider Non-Derivative Transactions at SMMT
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 12, 2024 Acquisition -- (Common Stock) 44052 22.7 24967852
Mar 28, 2024 P -- (Common Stock) 20000 3.71 50000
Mar 28, 2024 P -- (Common Stock) 26000 3.72 520814
Mar 28, 2024 P -- (Common Stock) 34321 3.72 24923800
Mar 27, 2024 P -- (Common Stock) 30000 3.75 30000
Dec 13, 2023 P -- (Common Stock) 5000 2.07 494814
Dec 12, 2023 X -- (Common Stock) 489814 1.44 489814
Dec 12, 2023 X -- (Common Stock) 315681 1.58 24889479
Mar 9, 2023 P -- (Common Stock) 804672 1.05 1178529
Mar 9, 2023 P -- (Common Stock) 6748629 1.05 9884095
Mar 9, 2023 P -- (Common Stock) 15973743 1.05 23395269
Mar 9, 2023 P -- (Common Stock) 16778415 1.05 24573798